24-hour urine protein | 190 |
Acceleration time | 249 |
Adenomyosis | 145 |
Adnexal cyst | 126 |
Adnexal mass | 126 |
Advanced ovarian cancer | 124 |
Amniotic fluid | 154 |
Androgens | 130 |
Assisted reproductive technologies | 33 |
Attitude | 275 |
Awareness | 1, 275 |
Bartholin abscess | 71 |
Bartholin cyst | 71 |
Benign ovarian neoplasm | 68 |
Bladder endometriosis | 145 |
Blood loss | 111 |
Breast-feeding | 255 |
Brenner tumors of the ovary | 22 |
Cancer | 314 |
Cardiophrenic lymph node | 124 |
Case-control studies | 154 |
Cervical cancer | 287 |
Cervical elongation | 219 |
Cesarean delivery | 177 |
Complications | 233 |
Congenital anomalies | 28 |
Contraception | 255 |
Costophrenic lymph node | 124 |
Cycle cancellation | 184 |
Cystinuria | 327 |
Delivery | 241 |
Ejection time | 249 |
Endometrial adenocarcinoma | 99 |
Endometrial cancer | 38, 233 |
Endometrioma | 117 |
Endometriosis | 117 |
Endoplasmic reticulum stress | 106 |
Endoplasmic reticulum to nucleus signalling-1 | 106 |
Eosinophil counts | 99 |
ERAS hysteroscopy | 51 |
ERAS protocol | 51 |
Fertility potential | 199 |
Fertility-sparing | 99 |
Fertility-sparing surgery | 287 |
Fetal anomalies | 28 |
Fetal heart axis | 95 |
Fetal intracranial hemorrhage | 268 |
Fetal situs | 95 |
Fibroid | 63 |
FSH to AMH ratio | 184 |
Getational diabetes mellitus | 106 |
GTN | 83 |
Healthcare | 1 |
Hyoscine | |
Hyperandrogenism | 130 |
Hyperechogenic colon | 327 |
Hypertensive diseases | 190 |
Hysteroscopy | 63 |
ICSI | 184 |
In-vitro fertilization | 14, 33 |
Infertility | 117, 154 |
Inner cell mass | 167 |
Intrahepatic cholestasis | 249 |
Intrauterine growth restriction | 190 |
Knowledge | 1, 275 |
Krukenberg tumor | 263 |
Laparoscopic surgery | 60, 117 |
Laparoscopy | 68, 75, 145, 233 |
Laparotomy | 233 |
Learning curve | 95 |
Learning module | 1 |
Leiomyoma | 63, 111 |
Lymphadenectomy | 60 |
Lymphatic failure | 38 |
Lymphocele | 60 |
Macrosomia | 241 |
Malignant Brenner tumors | 22 |
Manchester procedure | 219 |
Maternal health services | 222 |
Maternal outcome | 137 |
Mercury | 199 |
Metastasis | 263 |
Methyl mercury | 199 |
Micronutrients | 130 |
Mixed tumors | 22 |
Morcellation | 75 |
Myomectomy | 111 |
Neonatal outcome | 137 |
Neonatal shoulder width | 241 |
Neuregulin | 8 |
NRG-4 | 8 |
Office hysteroscopy | 51 |
Office surgery | 51 |
Oncological outcome | 233 |
Oncology | 60 |
Oocyte retrieval | 33, 184 |
Ovarian cystectomy | 126 |
Ovarian lifting | 126 |
Ovarian neoplasms | 263 |
Ovaries | 154 |
Ovary | 126 |
Partial hydatidiform mole and coexistent live fetus | 83 |
Partial molar pregnancy | 83 |
Patient satisfaction | 71 |
PCOS | 1 |
Pelvicalyceal echogenic foci | 327 |
Perinatal diagnosis | 28 |
Perinatal mortality | 190 |
Perinatal outcome | 8 |
Periodontal diseases | 275 |
Peripheral blood eosinophils | 99 |
Peripheral nodal recurrence | 38 |
Personalized medicine | 314 |
Pharmacogenetics | 314 |
Platelet rich plasma | 14 |
Polycystic ovary syndrome | 130 |
Poor responder | 14, 184 |
Post-abortive | 255 |
Postpartum | 255 |
Postpartum bleeding | 177 |
Predictors | 137 |
Preeclampsia | 8, 190 |
Pregnancy | 275 |
Pregnancy complications | 167 |
Pregnancy outcome | 199, 222 |
Pregnancy outcomes | 287 |
Premature ovarian insufficiency | 14 |
Prenatal diagnosis | 222, 268 |
Preterm delivery | 177 |
Progestin-only pill | 255 |
Proteinuria | 190 |
Pulmonary artery | 249 |
Rare tumors | 22 |
Rats | 154 |
ReceptivaDx | 117 |
Recurrence | 71 |
Reproduction | 199 |
Residency training | 95 |
Risk factors | 137 |
Sacrohysteropexy | 219 |
Sad fetus syndrome | 83 |
Sarcoma | 75 |
Sclerosing stromal tumor | 68 |
Semen quality | 199 |
Shoulder dystocia | 241 |
Stem cells | 154 |
Submucosal myoma resection | 63 |
Subxiphoid approach | 124 |
Surgical adhesions | 154 |
Survival | 38 |
Survival rate | 75 |
Suspension loop | 126 |
Termination of pregnancy | 28 |
TOLAC | 137 |
Translational genomics | 314 |
Treatment | 38 |
Trophectoderm | 167 |
Tumor grade | 99 |
Ultrasonography | 95, 222 |
Ultrasound | 145, 268 |
Unexpected malignancy | 75 |
Unfolded protein response | 106 |
Uterine artery occlusion | 111 |
Uterine carcinosarcoma | 60 |
Uterus | 154 |
Vaginal delivery | 177 |
VBAC | 137 |
Women’s healthcare | 314 |